• Home
  • NEW DAY MEDICINE
  • 8 (70) 2024
  • 3 -8 (70) 2024 - Khairullayeva G.S. - THE RELATIONSHIP BETWEEN CHANGES IN LIPID METABOLISM PARAMETERS AND THE SEVERITY OF COVID-19 INFECTION

3 -8 (70) 2024 - Khairullayeva G.S. - THE RELATIONSHIP BETWEEN CHANGES IN LIPID METABOLISM PARAMETERS AND THE SEVERITY OF COVID-19 INFECTION

THE RELATIONSHIP BETWEEN CHANGES IN LIPID METABOLISM PARAMETERS AND THE SEVERITY OF COVID-19 INFECTION

Khairullayeva G.S. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

The study included 135 patients aged 26-84 years (mean age 53.09±13.22 years) who underwent COVID-19 at least 2 months ago, divided into 3 groups: mild (1, n=64), moderate (2, n=64) and severe (3, n=7) the course of the infection. In patients, body mass index (BMI), waist circumference (WS), hip circumference (HS), waist-hip ratio (WS / HS), total cholesterol, triglycerides (TG), high-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol were determined, and the AIP index was calculated. Patients from the group of severe course of the new coronavirus infection have higher BMI, WS, AIP, TG, lower HDL cholesterol. The relative chance of severe COVID-19 is associated with an increased value of WS, AIP, TG and a lower HDL index.

Keywords: COVID-19, severity, high-density lipoprotein cholesterol, triglycerides, dyslipidemia, plasma atherogenicity index, AIP.

First page

12

Last page

15

For citation:Khairullayeva G.S. - THE RELATIONSHIP BETWEEN CHANGES IN LIPID METABOLISM PARAMETERS AND THE SEVERITY OF COVID-19 INFECTION//New Day in Medicine 8(70)2024 12-15 https://newdayworldmedicine.com/en/new_day_medicine/8-70-2024

List of References

  1. Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study //BMJ. 2020;369:m1966. doi:10.1136/bmj.m1966.
  2. Choi GJ, Kim HM, Kang H. The Potential Role of Dyslipidemia in COVID-19 Severity: an Umbrella Review of Systematic Reviews. //J Lipid Atheroscler. 2020;9(3):435-48. doi:10.12997/jla.2020.9.3.435.
  3. Sorokin AV, Karathanasis SK, Yang ZH, et al. COVID-19-Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches. //FASEB J. 2020;34(8):9843-53. doi:10.1096/fj.202001451.
  4. Onat A, Can G, Kaya H, Hergenc G. "Atherogenic index of plasma" (log10triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events. //J Clin Lipidol. 2010;4(2):89-98. doi:10.1016/j.jacl.2010.02.005.
  5. Yıldırım TO, Kaya Ş. The atherogenic index of plasma as a predictor of mortality in patients with COVID-19. //Heart Lung. 2021;50(2):329-33. doi:10.1016/j.hrtlng.2021.01.016.
  6. Dobiasova M, Frohlich J, Sedova M, et al. Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography. //Journal of Lipid Research. 2011;52(3):566-71. doi:10.1194/jlr.P011668.
  7. Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. //Cardiovasc Res. 2020;116(10):1666-87. doi:10.1093/cvr/cvaa106.
  8. Portincasa P, Krawczyk M, Smyk W, et al. COVID-19 and non-alcoholic fatty liver disease: Two intersecting pandemics. //Eur. J. Clin. Invest. 2020;50(10):e13338. doi:10.1111/eci.13338.
  9. Lighter J, Phillips M, Hochman S, et al. Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission. //Clin Infect Dis. 2020;71(15):896-7. doi:10.1093/ cid/ciaa415.
  10. Kimura LF, Sant’Anna MB, Andrade SA, et al. COVID-19 induces proatherogenic alterations in moderate to severe non-comorbid patients: A single-center observational study. //Blood Cells Mol Dis. 2021;92:102604. doi:10.1016/j.bcmd.2021.102604.
  11. Cirstea M, Walley KR, Russell JA, et al. Decreased high-density lipoprotein cholesterol level is an early prognostic marker for organ dysfunction and death in patients with suspected sepsis. //J Crit Care. 2017;38:289-94. doi:10.1016/j.jcrc.2016.11.041.
  12. Hu X, Chen D, Wu L, et al. Declined serum high-density lipoprotein cholesterol is associated with the severity of COVID-19 infection. //Clin Chim Acta. 2020;510:105-10. doi:10.1016/j.cca.2020.07.015.
  13. Masana L, Correig E, Ibarretxe D, et al. Low HDL and high triglycerides predict COVID-19 severity. //Scientific Reports. 2021;11(7217):1-9. doi:10.1038/s41598-021-86747-5.

    file

    download